Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Oncogene
|
May 9, 2022
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
L Francisco Lorenzo-Martín, Mauricio Menacho-Márquez, Natalia Fernández-Parejo, et al.
Neuron
|
May 1, 2018
Ras and Rap Signal Bidirectional Synaptic Plasticity via Distinct Subcellular Microdomains
Lei Zhang, Peng Zhang, Guangfu Wang, et al.
Scientific Reports
|
March 22, 2021
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
Miguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.
Molecular Oncology
|
September 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility
Dalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez, et al.
Nature Communications
|
September 7, 2018
RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
Berta Casar, Andrew P Badrock, Iñaki Jiménez, et al.
Science Advances
|
February 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species
Ana Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez, et al.
Cell Reports
|
March 14, 2019
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Tapesh Santra, Ana Herrero, Javier Rodriguez, et al.
Oncogene
|
March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer
Thaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Cancer Cell
|
August 13, 2015
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Ana Herrero, Adán Pinto, Paula Colón-Bolea, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Oncogene
|
May 9, 2022
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
L Francisco Lorenzo-Martín, Mauricio Menacho-Márquez, Natalia Fernández-Parejo, et al.
Neuron
|
May 1, 2018
Ras and Rap Signal Bidirectional Synaptic Plasticity via Distinct Subcellular Microdomains
Lei Zhang, Peng Zhang, Guangfu Wang, et al.
Scientific Reports
|
March 22, 2021
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
Miguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.
Molecular Oncology
|
September 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility
Dalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez, et al.
Nature Communications
|
September 7, 2018
RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
Berta Casar, Andrew P Badrock, Iñaki Jiménez, et al.
Science Advances
|
February 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species
Ana Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez, et al.
Cell Reports
|
March 14, 2019
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Tapesh Santra, Ana Herrero, Javier Rodriguez, et al.
Oncogene
|
March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer
Thaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Cancer Cell
|
August 13, 2015
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Ana Herrero, Adán Pinto, Paula Colón-Bolea, et al.
Page
of 7